The GBMRP recognizes the critical need for improved outcomes for individuals with glioblastoma. The GBMRP FY24 Transformative Consortium Award (TCA) is designed to support a multidisciplinary...more
The GBMRP recognizes the critical need for improved resources to advance the field of glioblastoma research and improve outcomes for individuals with glioblastoma. The FY24 GBMRP Resource Development...more
The FY24 GBMRP Hypothesis Development Award supports the exploration of highly innovative, untested, exploratory, high-risk/potentially high-gain concepts, theories, paradigms, and/or methods that...more
The FY24 ATRP FRA is intended to support conceptually innovative, high-risk/potentially high-reward research that could ultimately lead to critical discoveries and/or improvements in patient care or...more
The FY24 ATRP CRA is intended to support clinical research that evaluates disease-specific factors and interventions. Research supported by this mechanism is intended to generate clinically useful...more
The intent of the FY24 RTRP Qualitative Research Validation and Implementation Award mechanism is to support the continued investigation and further expansion of highly impactful resources for the...more
The intent of the DMRDP PTRCTA is to support clinical trials with eligible U.S. Service Members to evaluate treatments for post-traumatic stress disorder (PTSD) and/or traumatic brain injury (TBI)...more
The intent of the FY24 CRRP TRA is to support high-impact translational research that will accelerate innovative ideas into clinical applications, including health care products, technologies, and/or...more
The KCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of kidney cancer. Clinical trials may...more
For 2014, the Schwab Foundation for Social Entrepreneurship has recognized 37 individuals for their outstanding work in the field of social enterprise.